Company Overview of Grifols Biologicals, Inc.
Grifols Biologicals, Inc. researches, develops and produces therapeutic proteins from human plasma. Grifols Biologicals’ plant in Los Angeles, California has a total production capacity of 1.5 million liters per year. The company was incorporated in 2003 and is based in Los Angeles, California. Grifols Biologicals, Inc. operates as a subsidiary of Grifols, S.A.
5555 Valley Boulevard
Los Angeles, CA 90032-3548
Founded in 2003
Key Executives for Grifols Biologicals, Inc.
Similar Private Companies By Industry
|ViaCyte, Inc.||United States|
|CoDa Therapeutics, Inc.||United States|
|Global Blood Therapeutics, Inc.||United States|
|Plant Cell Technologies, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Grifols Biologicals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.